Docket Number:28A-960920
Inventor:Chi-Huey Wong, Yih-Shyun E. Cheng, Hui-Ming Yu, Ting-Jen R. Cheng
IP Status:US Provisional pending
Abstract:
We show that the crude extract of Plectranthus Amboinicus (PA) has anti-inflammatory effects and can inhibit AP-1 binding in vitro. The incubation of HUVEC cells with PA crude extract results in significant inhibition of the LPS-induced expression of IL-6, IL-12, MCP-1, and RANTES. After the crude extract being further fractionated with a preparative HPLC, the active components can server as a novel leads for potential AP-1 inhibitors. We also identify that in vitro AP-1 binding activity can be inhibited by some fractionats from actinomycetes fermentation broth. These fractions have inhibitory effects on AP-1activity and are useful as preventive or therapeutic agents for diseases in which excessive expression or activities of AP-1 are involved.
Fields of Application:
Medicine
Advantages when compared to the existing technologies:
- Novel lead
- Native Taiwanese Actinomycetes
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
